Valuation check: PYR's profit margin is -61.36%, below the Healthcare sector average of 21.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for PYR is -61.36% as of June 2026. That compares with -76.46% in the prior-year period — up 19.7% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Pyrogenesis Canada's historical trend and sector peers before judging valuation or financial health.
Over the past year, PYR's profit margin moved from -76.46% to -61.36% — a 19.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pyrogenesis Canada's valuation or profitability profile.
Against Healthcare companies, PYR currently prints -61.36% for profit margin, while the sector average sits near 21.34%. That is roughly 387.6% below the sector mean. Large gaps often invite a closer look at Pyrogenesis Canada's growth, margins, and balance sheet.
Profit Margin shows how effectively Pyrogenesis Canada converts resources into returns. At -61.36%, PYR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -76.46% in the prior-year period — up 19.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting PYR's profit margin (-61.36%), review year-over-year change from -76.46%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.